Companies: 10,795·Total market cap: $144.5T
bioAffinity Technologies, Inc.

bioAffinity Technologies, Inc.

BIAFNASDAQHealthcare● Active
$1.59
$-0.01(-0.59%)
Market Cap$7213221
P/E Ratio—
52W High$13.8
52W Low$0.693
Overview

bioAffinity Technologies, Inc. (BIAF) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

biaf · pe ratio · data through Jun 9, 2026

Core PE Ratio Metrics

Trailing 12 months · TTM

Insufficient PE history data (fewer than 3 valid fiscal years).

PE Ratio vs Peers

Medical - Diagnostics & Research · 5 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
bioAffinity Technologies, Inc.
bioAffinity Technologies, Inc.You
BIAF
$7MN/A—-$3.53
Artelo Biosciences, Inc.
Artelo Biosciences, Inc.
ARTL
$3MN/A—-$5.47
Carisma Therapeutics, Inc.
Carisma Therapeutics, Inc.
CARM
$0MN/A—-$1.46
GT Biopharma, Inc.
GT Biopharma, Inc.
GTBP
$4MN/A—-$5.14
Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Inc.
LIPO
$0MN/A—-$4.79
Psyence Biomedical Ltd.
Psyence Biomedical Ltd.
PBM
$0M14.15x—$1.78

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for bioAffinity Technologies, Inc. (BIAF) measures how much investors pay for each dollar of the company's trailing earnings. BIAF's current PE ratio of N/A is calculated by dividing its stock price of $1.59 by its TTM earnings per share of -$3.53.

PE Ratio = Stock Price ÷ EPS (TTM)
= $1.59 ÷ -$3.53 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.
Price historyFinancial statementsEarnings

Frequently asked questions

BIAF pe ratio · 6 questions

BIAF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $1.59 and TTM EPS of -$3.53. Data sourced from Financial Modeling Prep via BIAF's SEC 10-K and 10-Q filings.

BIAF PE ratioWhat is BIAF PE ratioCurrent PE ratio of BIAFBIAF PE ratio today

▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · bioAffinity Technologies, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09